In 2007, while investigating the role of H19 non-coding RNA in HCC progression, Imad’s team found that enhancing H19 expression under hypoxic conditions significantly enhanced tumorigenic potential in Hep3B cell lines, whereas knockdown of H19 attenuated the tumorigenic potential. Here, H19 is linked to hepatocellular carcinoma.